AbobotulinumtoxinA
Sponsors
ICLS Dermatology & Plastic Surgery, University of Central Florida, Galderma R&D, VA Greater Los Angeles Healthcare System, Johns Hopkins University
Conditions
Adolescent Idiopathic ScoliosisAwake BruxismBruxismCompartment Syndrome of LegFacial RhytidsGlabellar Frown LinesGlabellar LinesMasseter Muscle Hypertrophy
Phase 1
Phase 2
Phase 3
Phase 4
The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon
TerminatedNCT03639766
Start: 2018-08-31End: 2020-01-31Updated: 2021-06-30
Subject Satisfaction With AbobutulinumtoxinA Treatment
CompletedNCT03687736
Start: 2018-10-02End: 2019-12-04Updated: 2022-08-26
Abobotulinumtoxina Efficacy in Post-Traumatic Headache
CompletedNCT03928496
Start: 2013-08-01End: 2017-02-02Updated: 2019-04-26
Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis
RecruitingNCT03935295
Start: 2020-09-03End: 2026-12-31Target: 90Updated: 2025-12-09
The Treatment of Shoulder Pain in Hemiplegic Spastic Patients With Botulinum Toxin A
CompletedNCT04470401
Start: 2019-06-05End: 2021-03-05Updated: 2021-09-21
Chronic Exertional Compartment Syndrome (CECS) Treated With Abobotulinumtoxin A
CompletedNCT05466539
Start: 2024-04-25End: 2025-08-13Updated: 2025-10-21
Unknown Phase
Non-interventional Study, Long Term Treatment on Glabellar Lines With Dysport® in Subjects of Chinese Origin
CompletedNCT05089357
Start: 2021-11-11End: 2023-12-24Updated: 2025-07-09
Comparison of Dry Needling and Two Botulinum Toxins for Bruxism
CompletedNCT07452510
Start: 2026-01-09End: 2026-04-08Updated: 2026-05-20